1. A New Way Out of the Predicament of Anaplastic Thyroid Carcinoma From Existing Data Analysis
   Yikun Zhou et al, 2022, Frontiers in Endocrinology CrossRef
2. New Insights into Immune Cells and Immunotherapy for Thyroid Cancer
   Yujia Tao et al, 2023, Immunological Investigations CrossRef
3. TERT promoter mutations in thyroid cancer
   Michiko Matsuse et al, 2023, Endocrine Journal CrossRef
4. Aggressive variants of follicular cell-derived thyroid carcinoma: an overview
   Cristina Pizzimenti et al, 2022, Endocrine CrossRef
5. Non-Coding RNAs: Uncharted Mediators of Thyroid Cancer Pathogenesis
   Hossein Tabatabaeian et al, 2020, Cancers CrossRef
6. Clinicopathologic Analysis of Cathepsin B as a Prognostic Marker of Thyroid Cancer
   Eun-Kyung Kim et al, 2020, International Journal of Molecular Sciences CrossRef
7. Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer
   null Malfitano et al, 2019, Cancers CrossRef
8. Anaplastic Thyroid Carcinoma: An Update
   Arnaud Jannin et al, 2022, Cancers CrossRef
9. Update on Fundamental Mechanisms of Thyroid Cancer
   Alessandro Prete et al, 2020, Frontiers in Endocrinology CrossRef
10. The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy
    Antonio Matrone et al, 2019, Frontiers in Oncology CrossRef
11. Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules
    Patrick D. Chin et al, 2020, Endocrine Pathology CrossRef
12. Evaluation of E-Cadherin and β-Catenin Immunoreactivity for Determining Undifferentiated Cells in Anaplastic Thyroid Carcinoma
    Risa Kanematsu et al, 2021, Pathobiology CrossRef
13. A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer
    Cristina Romei et al, 2021, International Journal of Molecular Sciences CrossRef
14. Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with PTEN mutation: a case report and literature review
    Youjin Oh et al, 2024, Frontiers in Endocrinology CrossRef
15. Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer
    Tanner Fullmer et al, 2021, Frontiers in Endocrinology CrossRef
16. Pre- and Post-operative Circulating Tumoral DNA in Patients With Medullary Thyroid Carcinoma
    Raffaele Ciampi et al, 2022, The Journal of Clinical Endocrinology & Metabolism CrossRef
17. Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs
    Alessandro Prete et al, 2021, Cancers CrossRef